|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 475.34 USD | -1.38% |
|
-0.40% | +4.82% |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 27.48x | 5.52x | 1.89x | 8.32x | 18.76x | 19.65x | -.--% | 122B | ||
| 34.93x | 21.32x | 0.75x | 12.49x | 26.13x | 27.2x | 0.58% | 1,048B | ||
| 26.93x | 6.74x | -1.72x | 6.14x | 16.82x | 18.48x | 2.14% | 603B | ||
| 33.36x | 12747.64x | 0.15x | 7.57x | 15.52x | 16.03x | 2.68% | 452B | ||
| 17.83x | 6.6x | 1.07x | 4.42x | 10.88x | 12.24x | 3% | 327B | ||
| 21.97x | 6.12x | -9.14x | 5.47x | 13.3x | 14.44x | 2.81% | 283B | ||
| 20.86x | 4.89x | 0.93x | 4.4x | 12.18x | 13.17x | 2% | 259B | ||
| 14.29x | 6.31x | -9.3x | 5.31x | 10.95x | 12.88x | 3.5% | 219B | ||
| 24.02x | 18.48x | 3.36x | 6.34x | 11.18x | 14.51x | 2.75% | 198B | ||
| -46.93x | 8.22x | 0.33x | 5.62x | 31.07x | 62.18x | 2.53% | 162B | ||
| 12.67x | 1.62x | 0.28x | 3.1x | 7.84x | 8.86x | 6.92% | 142B | ||
| 11.83x | 5.35x | 0.24x | 3.23x | 8.71x | 9.36x | 4.14% | 124B | ||
| 11.58x | 1.23x | 3.28x | 2.17x | 6.97x | 7.98x | 5.54% | 105B | ||
| 11.93x | 4.36x | 0.96x | 2.69x | 7.78x | 8.89x | 3.68% | 101B | ||
| 23.92x | 5.42x | 1.39x | 8.11x | 15.32x | 16.04x | 1.85% | 74.7B | ||
| 39.53x | 5.3x | 2.23x | 8.9x | 29.42x | 30.53x | 0.49% | 53.47B | ||
| 44.7x | 1.19x | 23.99x | 2.75x | 9.74x | 27.84x | 3.68% | 54.43B | ||
| 20.58x | 1.67x | -0.13x | 1.72x | 8.18x | 13.74x | 0.48% | 53.37B | ||
| 19.03x | 1.92x | 4.06x | 3.45x | 12.97x | 14.55x | 2.17% | 43.44B | ||
| 35.64x | 17.04x | 0.16x | 5.95x | 27.05x | 26.13x | -.--% | 36.23B | ||
| Average | 20.31x | 643.85x | 1.24x | 5.41x | 15.04x | 18.74x | 2.55% | 223.12B | |
| Weighted average by Cap. | 23.38x | 1,301.91x | -0.24x | 7.11x | 17.01x | 19.58x | 2.26% |
- Stock Market
- Stocks
- VRTX Stock
- Sector Vertex Pharmaceuticals Incorporated
- Sector valuations
Select your edition
All financial news and data tailored to specific country editions
















